Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
about
Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Micro and Nano Material Carriers for Immunomodulation.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
P2860
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@ast
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@en
type
label
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@ast
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@en
prefLabel
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@ast
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@en
P2093
P2860
P1433
P1476
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
@en
P2093
Kelan A Hlavaty
Lonnie D Shea
Stephen D Miller
Xunrong Luo
P2860
P356
10.1016/J.CLIM.2015.03.013
P577
2015-03-21T00:00:00Z